$26.02
0.391.52%
Biodesix (BDSX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Biodesix (BDSX) ha pubblicato l'ultima guidance il agosto 5, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $108M - $114M per il periodo.
Rispetto alle previsioni precedenti, Biodesix ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Biodesix ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Biodesix. 20
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.89 | $-1.13 | $-0.94 | $-1.54 |
| Actual | $-0.71 | $-0.81 | $-0.49 | $-1.16 |
| Surprise | +20.2% | +28.3% | +47.9% | +24.7% |
| Revenue | ||||
| Estimate | $25.9M | $23.1M | $25.8M | $21.1M |
| Actual | $26.9M | $25.6M | $28.8M | $21.8M |
| Surprise | +3.54% | +10.7% | +11.3% | +3.32% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.75 | $-0.43 | $-0.60 | $-0.47 |
| Revenue | ||||
| Consensus | $27.5M | $32.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.71 | $-0.89 | 20.2 % |
| Q1 | May 4, 2026 | $-0.81 | $-1.13 | 28.3 % |
| Q4 | Feb 26, 2026 | $-0.49 | $-0.94 | 47.9 % |
| Q3 | Nov 3, 2025 | $-1.16 | $-1.54 | 24.7 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $26.86M | $25.94M | 3.54 % |
| Q1 | May 4, 2026 | $25.56M | $23.09M | 10.7 % |
| Q4 | Feb 26, 2026 | $28.76M | $25.83M | 11.3 % |
| Q3 | Nov 3, 2025 | $21.77M | $21.07M | 3.32 % |